Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

STING agonist-loaded mesoporous manganese-silica nanoparticles for vaccine applications

Journal of Controlled Release(2023)10.1016/j.jconrel.2023.03.036Source: DataRank Database

STING agonist-loaded mesoporous manganese-silica nanoparticles for vaccine applications is a research paper published in Journal of Controlled Release (2023). On theSindex it has a DataRank of 0. It has been cited 52 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access52 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (11 grants)OA: greenTopics (16)IDs (PubMed, PMC)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (13)

Hannah E. Dobson ORCID,Mengjie Yu ORCID,Wang Gong ORCID,Xiaoqi Sun ORCID,Kyong Soo Park ORCID

Live enrichment

PubMed:36948420 PMC:PMC10164691

National Institutes of Health

Grant: P30CA046592

National Institutes of Health

Grant: R01DE026728

National Institutes of Health

Grant: R01DE030691

National Institutes of Health

Grant: R01NS122536

National Institutes of Health

Grant: R01DK125087

National Institutes of Health

Grant: R01CA271799

National Institutes of Health

Grant: U01CA210152

National Institutes of Health

Grant: R01DE031951

National Institutes of Health

Grant: HHSN272201300006C

NIDCR NIH HHS

Grant: U01 DE029255

NIGMS NIH HHS

Grant: R01 GM139823

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10164691/pdf/nihms-1888481.pdf

publisherhttps://api.elsevier.com/content/article/PII:S0168365923002043?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0168365923002043?httpAccept=text/plain

MeSH Terms

AnimalsHumansMiceManganeseSilicon DioxideVaccinesImmunotherapyNanoparticlesHereditary Sensory and Motor NeuropathyCOVID-19SARS-CoV-2

Keywords

VaccineImmunotherapyNeoantigenMesoporous Silica NanoparticlesSting Agonist

Related Papers (9)

A mannosylated polymer with endosomal release properties for peptide antigen delivery

N/A

0.483DataRank · unranked

Journal of Controlled Release(2023)

co-citedsame journal

10.1016/j.jconrel.2023.03.004

A bi-adjuvant nanovaccine that potentiates immunogenicity of neoantigen for combination immunotherapy of colorectal cancer

Science Advances(2020)

co-cited

10.1126/sciadv.aaw6071

Lipid-Polyglutamate Nanoparticle Vaccine Platform

ACS Applied Materials & Interfaces(2021)

co-cited

10.1021/acsami.0c20607

Responsive Multivesicular Polymeric Nanovaccines that Codeliver STING Agonists and Neoantigens for Combination Tumor Immunotherapy

Advanced Science(2022)

co-cited

10.1002/advs.202201895

Linked CD4+/CD8+ T cell neoantigen vaccination overcomes immune checkpoint blockade resistance and enables tumor regression

Journal of Clinical Investigation(2023)

co-cited

10.1172/jci164258

Revisiting Coley’s Toxins: Immunogenic Cardiolipins from Streptococcus pyogenes

N/A

0.639DataRank · unranked

Journal of the American Chemical Society(2023)

co-cited

10.1021/jacs.3c07727

A Cancer Nanovaccine for Co-Delivery of Peptide Neoantigens and Optimized Combinations of STING and TLR4 Agonists

ACS Nano(2024)

co-cited

10.1021/acsnano.3c04471

Comparing neoantigen cancer vaccines and immune checkpoint therapy unveils an effective vaccine and anti-TREM2 macrophage-targeting dual therapy

N/A

0.539DataRank · unranked

Cell Reports(2024)

co-cited

10.1016/j.celrep.2024.114875

CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation.

N/A

14.6DataRank · unranked

The Journal of experimental medicine(1995)

co-cited

10.1084/jem.182.2.459